Caris Life Sciences Secures $1.2 Billion Credit Facilities from Blackstone and Blue Owl

Caris Life Sciences has successfully secured up to $1.2 billion in senior secured credit facilities to bolster its financial position and support future growth. The financing package is provided by investment funds managed by industry giants Blue Owl Capital and Blackstone. The deal is structured to include an initial $400 million term loan, alongside $300 million specifically earmarked for strategic acquisitions. Additionally, the agreement provides a $500 million incremental uncommitted facility to support long-term expansion initiatives. This massive capital injection follows positive clinical study results and aims to fund ongoing operations and M&A activities. The transaction underscores the growing role of private credit in the biotechnology sector, providing a bullish signal for institutional lenders like Blackstone and Blue Owl.